Roboz, G. J., Pabst, T., Aribi, A., Brandwein, J. M., Döhner, H., Fiedler, W., Riether, C., Gandini, D., Geddes, M., Hou, J.-Z., Yee, K., Hultberg, A., Huselton, E., Jacobs, J., Zabrocki, P., Lech-Marańda, E., Louwers, M., Nottage, K., Platzbecker, U., Rampal, R., Salman, M., Shah, P., Wilson, K., Stuart, M., Subklewe, M., Sumbul, A., Wang, E. S., Wierzbowska, A., Yao, B., Patel, R., George, A., Islam, N., Smith, C., Boyiadzis, M. and Borthakur, G. (2020) “Cusatuzumab combined with venetoclax with or without azacitidine in unfit patients with newly diagnosed acute myeloid leukemia: phase Ib ELEVATE study”, Haematologica. Pavia, Italy. doi: 10.3324/haematol.2026.300917.